Company news
Achieve Life Sciences, Inc. news in 2021
Achieve Life Sciences, Inc.'s news releases, calls and decks from 2021, newest first.
Achieve Life Sciences Announces $25 Million Loan Facility from Silicon Valley Bank to Fund Cytisinicline Smoking Cessation Clinical Development
December 21, 2021
Achieve Life Sciences Announces Phase 3 ORCA-2 Trial of Cytisinicline in Smoking Cessation Clears Final Review by Data Safety Monitoring Committee (DSMC)
November 21, 2021
Achieve Reports Financial Results for Third Quarter 2021 and Provides Update on Cytisinicline Development
November 8, 2021
Achieve Life Sciences Announces FDA Acceptance of IND Application for Cytisinicline’s Second Planned Indication for Nicotine E-cigarette Cessation
November 1, 2021
Achieve Life Sciences to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 9, 2021
October 25, 2021
Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 21st Annual Society for Research on Nicotine & Tobacco (SRNT-E) Virtual Conference
September 13, 2021
Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Awards
August 12, 2021
Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update
August 10, 2021
Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing and Administration Regimen
August 10, 2021
Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021
August 2, 2021
Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use
July 21, 2021
Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline
June 28, 2021
Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction
June 2, 2021
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 26, 2021
Achieve Life Sciences Announces Pricing of $20 Million Underwritten Public Offering
May 24, 2021
Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate Update
May 12, 2021
Achieve Life Sciences, Inc. to Host Virtual Non-Deal Roadshow on Tuesday, April 27, 2021
April 21, 2021
Achieve Announces Publication of the RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix(R) (varenicline) in Addiction
March 24, 2021
Achieve Life Sciences Announces Appointment of Dr. Bridget Martell and Dr. Cindy Jacobs to Board of Directors
March 14, 2021
Achieve Reports Financial Results for Fourth Quarter and Year-End 2020 and Provides Corporate Update
March 10, 2021
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call and Webcast on March 11, 2021
March 3, 2021
Calls in 2021
- Achieve Life Sciences (NASDAQ:ACHV) Q3 2021 Earnings Call
Nov 9, 2021
Transcript - Achieve Life Sciences (NASDAQ:ACHV) Q2 2021 Earnings Call
Aug 12, 2021
Transcript - Achieve Life Sciences (NASDAQ:ACHV) Q1 2021 Earnings Call
May 13, 2021
Transcript - Achieve Life Sciences (NASDAQ:ACHV) Q4 2020 Earnings Call
Mar 11, 2021
Transcript